27
Participants
Start Date
February 28, 2005
Primary Completion Date
January 31, 2010
topotecan hydrochloride
Duke Comprehensive Cancer Center, Durham
Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham
University of Mississippi Cancer Clinic, Jackson
Regional Cancer Center at Singing River Hospital, Pascagoula
Mount Carmel Health - West Hospital, Columbus
Charles M. Barrett Cancer Center at University Hospital, Cincinnati
David L. Rike Cancer Center at Miami Valley Hospital, Dayton
William Beaumont Hospital - Royal Oak Campus, Royal Oak
Saint Louis University Cancer Center, St Louis
Methodist Estabrook Cancer Center, Omaha
Oklahoma University Cancer Institute, Oklahoma City
Cancer Care Associates - Midtown Tulsa, Tulsa
Kaiser Permanente Medical Center - Los Angeles, Los Angeles
Olive View - UCLA Medical Center Foundation, Sylmar
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles
Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford
George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus, New Britain
Yale Cancer Center, New Haven
Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah
University of Chicago Cancer Research Center, Chicago
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Holden Comprehensive Cancer Center at University of Iowa, Iowa City
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus
Riverside Methodist Hospital Cancer Care, Columbus
Women and Infants Hospital of Rhode Island, Providence
National Cancer Institute (NCI)
NIH
Gynecologic Oncology Group
NETWORK